TGF beta 2 Monoclonal Antibody

$Lane 1: A549 cell lysates probed with TGF beta 2 Monoclonal Antibody, Unconjugated (bsm-51483M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.$

Lane 1: A549 cell lysates probed with TGF beta 2 Monoclonal Antibody, Unconjugated (bsm-51483M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

$Lane 1:: MCF-7 cell lysates; Lane 2: Huvec cell lysates probed with TGF beta 2 Monoclonal Antibody, Unconjugated (bsm-51483M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.$

Lane 1:: MCF-7 cell lysates; Lane 2: Huvec cell lysates probed with TGF beta 2 Monoclonal Antibody, Unconjugated (bsm-51483M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

Predicted Reactivity

Human

Overview
Catalog #	bsm-51483M
Product Name	TGF beta 2 Monoclonal Antibody
Applications	WB
Predicted Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Mouse
Source	Recombinant human TGFB2.
Clonality	Monoclonal
Clone #	G1F2
Concentration	0.5ug/ul
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	7042
Swiss Prot	P61812
Subcellular location	Secreted
Synonyms	TGF B2; BSC 1 cell growth inhibitor; BSC-1 cell growth inhibitor; BSC1 cell growth inhibitor; Cetermin; G TSF; G-TSF; Glioblastoma derived T cell suppressor ; Glioblastoma derived T cell suppressor factor; Glioblastoma-derived T-cell suppressor factor; GTSF; MGC116892; Polyergin; TGF beta2; TGF-beta-2; TGF-beta2; TGFB 2; TGFB2; TGFB2_HUMAN; Transforming growth factor beta 2; Transforming growth factor beta-2.
Background	TGF-beta 2 has suppressive effects on interleukin-2 dependent T-cell growth.
Application Dilution
WB	=1:500-2000Ôºå